Financials

News Discussions Technicals Seasonals

GUARD fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Guard Therapeutics International AB is a pharmaceutical company, which engages in the research, development, and commercialization of medical treatment and diagnosis based on alpha-1-microglobulin. It focuses on the treatment of pre-eclampsia and acute kidney injury. The company was founded by Bo Åkerström, Tomas Jörgen Eriksson, Stefan Hansson, Gram Magnus on April 4, 2008 and is headquartered in Stockholm, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

GUARD has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company